ArticleBiomolecules & therapeutics2026
RBM15-Mediated m6A Modification Regulates Proliferation and Migration of Pancreatic Cancer Cells via the lncRNA LINC01320/miR-1287-5p/FBXO11 Axis.
Article in Biomolecules & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer (PC) is life-threatening with unfavorable outcomes. RBM15, an m6A methylation modulator, is a potential biomarker for cancers. This study delved into the mechanism of RBM15-mediated m6A modification in PC. RBM15, LINC01320, miR-1287-5p, and FBXO11 levels in PC tissues and cells were examined. Cell proliferation, invasion, and migration were determined. The enrichment of m6A on LINC01320 and LINC01320 stability were detected. Joint experiments were designed to analyze the role of LINC01320 or FBXO11 in PC cell growth. The tumor xenograft in nude mice was established, and the effect of RBM15 on PC cell proliferation was verified in vivo. RBM15, LINC01320, and FBXO11 were significantly increased in PC, while miR-1287-5p was decreased. RBM15 downregulation reduced PC cell proliferation, invasion, and migration. In mechanism, RBM15-mediated m6A modification increased LINC01320 stability and its expression, thus upregulating FBXO11 transcription by competitively binding to miR-1287-5p. Overexpression of LINC01320 or FBXO11 abated the inhibition of RBM15 downregulation on PC cells. RBM15 knockdown inhibited tumor size and weight and reduced the positive rate of Ki67 through LINC01320/miR-1287-5p/FBXO11 axis. Overall, RBM15-mediated m6A modification increases LINC01320 stability and promotes its expression and FBXO11 transcription by competitive binding to miR-1287-5p, ultimately promoting PC cell growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.